Apollomics Inc.
APLMW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 14 institutions reported holding it in 13F filings for Q2 2026, worth $53.6K in total; no superinvestor holds it.
Other share classesAPLM
Holders of 5% or more of APLMW
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Apollomics Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Apollomics Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Apollomics Inc., newest first.
No Schedule 13D or 13G filings on Apollomics Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Apollomics Inc. shares.
No Form 144 notices for Apollomics Inc. are on file.